Retinal Detachment
Company launches phase II trial for novel approach for treatment of RRD
Published in Medical Letter on the CDC and FDA, May 23rd, 2004
Retinal detachment is a potentially blinding condition that occurs when the retina, a layer of sensory tissue that captures and processes visual information, is separated from the underlying retinal pigment epithelium. Current first-line therapy for RRD is surgical intervention. Inspire is investigating INS37217 Ophthalmic as the first pharmaceutical treatment for this debilitating condition.
The double-masked, randomized, placebo-controlled, parallel-dose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Hepatitis C Epidemiology
Risk factors for hepatitis C in Alaska natives reported - Hepatology
Chronic liver disease mortality in the United States reported - Malaria Transmission
Isonicotinic acid hydrazide inhibits malaria transmission in mosquito - Malaria Vaccine
Plasmodium falciparum peptides bind to human hepatocytes - Pancreatic Cancer
No link found between IGF or IGF-binding protein and pancreatic cancer - AIDS Therapy
FDA-approved study launched to treat AIDS patients in virologic failure - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
